American Society of Hematology

2018 ASH Meeting on Lymphoma Biology

August 2-5, 2018
Washington, DC

The goal of the meeting is to further the understanding of lymphoma pathogenesis and accelerate new therapies by providing a forum for scientific exchange. The four-day meeting consists of didactic sessions, abstract presentations, and interactive workshops/panel discussions. The target audience for this meeting includes laboratory-based scientists, translational investigators, pharmaceutical scientists, and others interested in lymphoma science.

View program

Program Co-Chairs

  • Riccardo Dalla-Favera, MD
    Columbia University, New York, NY
  • Kojo Elenitoba-Johnson, MD
    University of Pennsylvania, Philadelphia, PA
  • Freda Stevenson, Dphil
    University of Southampton Medical School, Southampton, UK

Steering Committee Members

  • John Byrd, MD, The Ohio State University, Columbus, OH
  • Elias Campo, MD, PhD, Hospital Clinic, Barcelona, Spain
  • Ralf Kuppers, PhD, University of Duisburg-Essen, Essen, Germany
  • Ron Levy, MD, Stanford University, Stanford, CA
  • Greg Nowakowski, MD, Mayo Clinic, Rochestern, MN
  • Margaret Shipp , MD, Dana-Farber Cancer Institute, Boston, MA
  • Louis Staudt, MD, PhD, NCI, NIH, Bethesda, MD
  • Catherine Wu, MD, Dana-Farber Cancer Institute, Boston, MA


For more information about abstracts and speakers, please contact

For information about corporate support, please contact

Please submit all general inquiries to

Related Item

back to top